Hepatitis B virus (HBV) precore mutants are associated often with highly productive infection in hepatitis B surface antigen (HBsAg) carriers lacking hepatitis B e antigen (HBeAg) but positive for anti-HBe, rendering serological identification of infectious individuals unreliable. Although considere
Prevalence of precore-defective mutant of hepatitis B virus in HBV carriers
✍ Scribed by Hirofumi Niitsuma; Motoyasu Ishii; Yukie Saito; Masahito Miura; Koju Kobayashi; Hitoshi Ohori; Takayoshi Toyota
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 689 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Two hundred and seventy‐three serum specimens from hepatitis B virus (HBV) carriers were examined for the presence of a characteristic one point mutation at nucleotide (nt) 1896 from the EcoRI site of the HBV genome in the precore region (the preC mutant) using restriction fragment length polymorphism (RFLP) analysis. This assay approach could detect preC mutants or wild‐type sequences when either form constituted more than 10% of the total sample. Overall, 65.5% (76/116) of HBeAg‐positive carriers had only the preC wild‐type. All HBeAg‐positive asymptomatic carriers (n = 14) had only the preC wild‐type. In patients with chronic hepatitis B and in anti‐HBe‐positive asymptomatic carriers, increased prevalence of the preC mutant was associated with the development of anti‐HBe antibodies and normalization of the serum alanine aminotransferase concentration. Furthermore, 27 (29.0%) of 93 HBeAg‐negative carriers had unexpectedly preC wild‐type sequences only. Direct sequencing of the HBV precore region of HBV specimens from 24 patients revealed no mutation at nt 1896, supporting the specificity of the RFLP analysis. These results suggest that RFLP analysis was accurate for the detection of the preC mutation and that the absence of serum HBeAg cannot be explained solely by the dominance of the preC mutant. © 1995 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## BACKGROUND. A point mutation from G to A at nucleotide (nt) 1896 of the precore region of hepatitis B virus (HBV) DNA has been shown to be associated with fulminant and severe hepatitis. Further studies have suggested that this point mutation, together with additional mutations in the precore p
## Abstract One hundred forty‐two precore/core sequences were obtained from Gambian chronic hepatitis B virus (HBV) carriers and the predominant variants defined. The two point mutations, from A to T and G to A at nt positions 1762 and 1764 in the basic core promoter region, were found in only 7/99
To elucidate the influence of hepatitis delta virus (HDV) superinfection on the clearance of hepatitis B virus (HBV) associated antigens in HBV carriers, we examined for antibody to hepatitis delta antigen (anti-HD) serial sera collected from 1,029 HBV carriers in Kure, Japan. Of the 242 HBV carrier
This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ؍ 60
## Abstract Mutations in the precore region of hepatitis B virus (HBV) have been associated with failure of expression of HBV e‐antigen (HBeAg), however, the prevalence of these and other mutations in HBV carriers without overt chronic liver disease remains uncertain. Homosexual or bisexual males (